DE60132851D1 - Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension - Google Patents

Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension

Info

Publication number
DE60132851D1
DE60132851D1 DE60132851T DE60132851T DE60132851D1 DE 60132851 D1 DE60132851 D1 DE 60132851D1 DE 60132851 T DE60132851 T DE 60132851T DE 60132851 T DE60132851 T DE 60132851T DE 60132851 D1 DE60132851 D1 DE 60132851D1
Authority
DE
Germany
Prior art keywords
alleviation
hypertension
medicines
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132851T
Other languages
English (en)
Other versions
DE60132851T2 (de
Inventor
Wataru Okawa
Yuki Mitsui
Takuya Watanabe
Yasuteru Eguchi
Hirokazu Takahashi
Atsushi Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of DE60132851D1 publication Critical patent/DE60132851D1/de
Application granted granted Critical
Publication of DE60132851T2 publication Critical patent/DE60132851T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/02—Treating green coffee; Preparations produced thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L23/00—Soups; Sauces; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60132851T 2000-07-12 2001-07-12 Arzneimittel zur Vorbeugung, Linderung oder Behandlung von Hypertonie Expired - Lifetime DE60132851T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000210865 2000-07-12
JP2000210865 2000-07-12

Publications (2)

Publication Number Publication Date
DE60132851D1 true DE60132851D1 (de) 2008-04-03
DE60132851T2 DE60132851T2 (de) 2009-03-26

Family

ID=18707066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132851T Expired - Lifetime DE60132851T2 (de) 2000-07-12 2001-07-12 Arzneimittel zur Vorbeugung, Linderung oder Behandlung von Hypertonie

Country Status (3)

Country Link
US (2) US6458392B1 (de)
EP (1) EP1172112B8 (de)
DE (1) DE60132851T2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713566B2 (en) * 1999-12-21 2010-05-11 Zapp Loretta M Method for enhancing post-processing content of beneficial compounds in beverages
DE60126859T2 (de) * 2000-04-27 2008-01-31 Ntt Docomo Inc. Zellularen Telefon mit Fehlerfeststellungsverfahren und Fehlerfeststellungsgerät
US6458392B1 (en) * 2000-07-12 2002-10-01 Kao Corporation Preventive, alleviative or remedy for hypertension
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
US6991812B2 (en) * 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
EP1483283A4 (de) 2002-03-13 2007-04-11 Signum Biosciences Inc Modulation der proteinmethylierung und phosphoproteinphosphat
CN100446685C (zh) * 2002-06-28 2008-12-31 花王株式会社 饮料
US20040253356A1 (en) * 2003-06-11 2004-12-16 Applied Food Sciences, Llc Extraction method for use in extracting beneficial compounds from coffee beans
US20070237845A1 (en) * 2004-03-01 2007-10-11 Fhg Corporation D/B/A/ Intergrity Nutraceuticals Methods and materials for reducing or eliminating risk factors associated with syndrome x
US20070196520A1 (en) * 2004-03-01 2007-08-23 Fhg Corporation D/B/A Nutraceuticals Methods and materials for reducing or eliminating risk factors associated with syndrome x
US9700590B2 (en) * 2004-03-01 2017-07-11 In Ingredients, Inc. Methods and materials for reducing or eliminating risk factors associated with syndrome X
JP2006160721A (ja) * 2004-11-09 2006-06-22 Kao Corp 大脳疲労回復剤
US7666409B2 (en) * 2004-11-16 2010-02-23 Kao Corporation Low salt liquid seasoning with antihypertensive activity
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US8221804B2 (en) 2005-02-03 2012-07-17 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
JP4955928B2 (ja) * 2005-03-01 2012-06-20 花王株式会社 クロロゲン酸類組成物の製造方法
AU2009242334B2 (en) * 2008-04-30 2014-05-01 Société des Produits Nestlé S.A. Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee
CN103266376A (zh) * 2013-04-16 2013-08-28 浙江春江轻纺集团有限责任公司 一种阻燃包芯纱及加工方法
US11071767B2 (en) 2014-04-13 2021-07-27 Marmar Investment Sp. Z O.O. Dietary compositions for reducing blood glucose levels and for weight management
CN108030797A (zh) * 2017-12-25 2018-05-15 浙江工业大学 杭白菊提取物在制备防治心肌肥厚的药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5133184B2 (de) * 1971-10-21 1976-09-17
NL8400759A (nl) * 1984-03-09 1985-10-01 Douwe Egberts Tabaksfab Werkwijze voor de gelijktijdige verwijdering van caffeine en andere potentieel voor de gezondheid nadelige stoffen uit koffie.
DE3737109A1 (de) * 1987-11-02 1989-05-11 Jacobs Suchard Gmbh Verfahren zur konservierung von rohkaffee-extrakt
DE3806372A1 (de) * 1988-02-24 1989-08-31 Code Kaffee Handel Verfahren zur abtrennung und gewinnung von coffein aus rohkaffee und zur gewinnung von entcoffeiniertem kaffee
US4911941A (en) * 1988-08-05 1990-03-27 General Foods Corporation Method for decaffeinating coffee with a supercritical fluid
JPH04145048A (ja) 1990-10-04 1992-05-19 T Hasegawa Co Ltd 精製クロロゲン酸の製法
JP2665990B2 (ja) 1990-10-04 1997-10-22 長谷川香料株式会社 精製クロロゲン酸の製造方法
JPH08259453A (ja) 1993-12-06 1996-10-08 Nikka Uisukii Kk 果実ポリフェノール含有果汁とその製造方法、酸化防止剤、血圧降下剤、抗変異原性作用剤、アレルギー抑制剤、抗う蝕剤及び消臭剤
CA2128293C (en) 1993-12-06 2002-09-03 Masayuki Tanabe Fruit polyphenols and medicinal compositions containing them
JPH08157816A (ja) * 1994-12-02 1996-06-18 Oriza Yuka Kk 天然抗酸化剤およびその製造方法
JP2000063827A (ja) 1998-08-26 2000-02-29 Dainippon Ink & Chem Inc 抗酸化剤の製造方法
US6458392B1 (en) 2000-07-12 2002-10-01 Kao Corporation Preventive, alleviative or remedy for hypertension

Also Published As

Publication number Publication date
EP1172112B1 (de) 2008-02-20
US6458392B1 (en) 2002-10-01
EP1172112B8 (de) 2008-06-11
US7125573B2 (en) 2006-10-24
EP1172112A2 (de) 2002-01-16
DE60132851T2 (de) 2009-03-26
US20020192317A1 (en) 2002-12-19
US20020022062A1 (en) 2002-02-21
EP1172112A3 (de) 2002-10-30

Similar Documents

Publication Publication Date Title
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
NO20040936L (no) Plaster for behandling av dysfunksjoner og forstyrrelser ved neglevekst.
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ZA200300434B (en) Medicinal herbal compounds for the prevention and treatment of diabetes.
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE369130T1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition